Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...

Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...

Despite a significant increase in revenue, Cytokinetics Inc (CYTK) faces challenges with growing expenses and strategic ...

Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations ...

IST, the barometer index, the S&P BSE Sensex, declined 751.63 points or 1% to 73,865. The Nifty 50 index dropped 224.55 points or 1% to 22,320.50.

The company posted earnings per share (EPS) of $1.16,... ByInvesting.com• 4 hours ago Earnings call transcript: Sanofi Q4 2024 sees strong growth in sales, EPS Sanofi (EPA:SASY) (NASDAQ:SNY) reported ...

Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...

NVAX reports encouraging fourth-quarter results. It completes the sale of its Czech Republic manufacturing unit to Novo ...